Effect of blood transfusion in combination with Dextran-40 and hypertonic saline solution on cardiopulmonary haemodynamics of endotoxin (lipopolysaccharide) shock in buffalo calves.
The intravenous (i.v.) infusion of lipopolysaccharide (LPS) of E. coli endotoxin in buffalo calves (n = 15) at 5 microg/kg bw per h for 3 h caused a significant (p<0.05) fall in plasma volume, blood volume, haematocrit haemoglobin, and systolic, diastolic and pulse pressure, mean arterial pressure and central venous pressure (CVP), with a marked rise in respiration. Treatment with a combination of i.v. infusion of 7.2% hypertonic saline solution, Plasmex-D-40 (Dextran-40) and blood successfully alleviated hypovolaemia, and raised systolic, diastolic and pulse pressure, mean arterial pressure and central venous pressure. The whole blood was collected from apparently healthy male buffalo calves 24 h prior to infusion and was transfused without cross-matching. No significant fall in haemoglobin, haematocrit and body temperature was observed after transfusion. All these values tended to remain near normal levels. However, this combination of treatment had no effect on high respiratory rate. A one-time blood transfusion did not evoke any cross-reaction and was helpful in raising haematocrit and haemoglobin close to pre-infusion values. The general symptoms of restlessness, respiratory distress, profuse salivation, violent movement of the ears, snoring, intermittent struggle, etc. were markedly reduced. All the treated animals became quiet and lay with eyes open and survived the 7 h of observation.
Singh
D V
DV
Department of Veterinary Physiology, College of Veterinary Science, Punjab Agricultural University, Ludhiana, India. digvijay231@rediffmail.com
Singh
R
R
Sodhi
S P S
SP
D000818:Animals; D001803:Blood Transfusion / Q000662:veterinary*; D002020:Buffaloes; D003911:Dextrans / Q000627:therapeutic use*; D008070:Lipopolysaccharides / Q000009:adverse effects*; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use*; D012769:Shock / Q000139:chemically induced / Q000628:therapy / Q000662:veterinary*
D003911:Dextrans; D008070:Lipopolysaccharides; D012462:Saline Solution, Hypertonic